JP2019011379A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019011379A5 JP2019011379A5 JP2018203314A JP2018203314A JP2019011379A5 JP 2019011379 A5 JP2019011379 A5 JP 2019011379A5 JP 2018203314 A JP2018203314 A JP 2018203314A JP 2018203314 A JP2018203314 A JP 2018203314A JP 2019011379 A5 JP2019011379 A5 JP 2019011379A5
- Authority
- JP
- Japan
- Prior art keywords
- edible
- yellow
- solid preparation
- oral solid
- red
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004611 light stabiliser Substances 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 2
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 claims 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 claims 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 1
- -1 brown iron oxide Chemical compound 0.000 claims 1
- 229940067573 brown iron oxide Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 claims 1
- PNCPYILNMDWPEY-QGZVFWFLSA-N silodosin Chemical compound N([C@@H](CC=1C=C(C=2N(CCCO)CCC=2C=1)C(N)=O)C)CCOC1=CC=CC=C1OCC(F)(F)F PNCPYILNMDWPEY-QGZVFWFLSA-N 0.000 claims 1
- 229960004953 silodosin Drugs 0.000 claims 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018203314A JP7316777B2 (ja) | 2017-06-30 | 2018-10-29 | 光安定性に優れたシロドシン含有経口固形製剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017129468A JP6427634B1 (ja) | 2017-06-30 | 2017-06-30 | 光安定性に優れたシロドシン含有経口固形製剤 |
| JP2018203314A JP7316777B2 (ja) | 2017-06-30 | 2018-10-29 | 光安定性に優れたシロドシン含有経口固形製剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017129468A Division JP6427634B1 (ja) | 2017-06-30 | 2017-06-30 | 光安定性に優れたシロドシン含有経口固形製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019011379A JP2019011379A (ja) | 2019-01-24 |
| JP2019011379A5 true JP2019011379A5 (OSRAM) | 2021-03-11 |
| JP7316777B2 JP7316777B2 (ja) | 2023-07-28 |
Family
ID=87378530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018203314A Active JP7316777B2 (ja) | 2017-06-30 | 2018-10-29 | 光安定性に優れたシロドシン含有経口固形製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7316777B2 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7391521B2 (ja) * | 2019-03-12 | 2023-12-05 | 東和薬品株式会社 | 勃起不全治療用医薬組成物 |
| CA3199523A1 (en) * | 2020-12-23 | 2022-06-30 | Alphanavi Pharma Inc. | Oral solid preparation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4783573B2 (ja) * | 2004-02-20 | 2011-09-28 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ワルファリンカリウム含有医薬組成物とその製造方法 |
| JP5452050B2 (ja) * | 2009-03-27 | 2014-03-26 | 杏林製薬株式会社 | イミダフェナシンを含有する口腔内崩壊錠 |
| EP2979697A4 (en) * | 2013-03-26 | 2016-11-30 | Kissei Pharmaceutical | PREPARATION FOR ORAL ADMINISTRATION WITH MASKED BITTERNITY OF SILODOSINE |
| JP6243265B2 (ja) * | 2014-03-20 | 2017-12-06 | 日医工株式会社 | ロスバスタチン含有医薬製剤 |
| WO2016051782A1 (ja) * | 2014-09-30 | 2016-04-07 | キッセイ薬品工業株式会社 | 苦味を有する薬剤の苦味をマスキングした経口投与製剤 |
| JP2016138073A (ja) * | 2015-01-29 | 2016-08-04 | 大原薬品工業株式会社 | 安定性を改善した、シロドシンを含有する錠剤 |
| JP6768309B2 (ja) * | 2015-04-28 | 2020-10-14 | 大原薬品工業株式会社 | 光安定性を向上したシロドシン含有着色錠剤 |
| JP2017014151A (ja) * | 2015-07-01 | 2017-01-19 | 大原薬品工業株式会社 | 光安定性を向上した、シロドシンを含有する有核錠 |
| JP2018083809A (ja) * | 2016-11-16 | 2018-05-31 | 沢井製薬株式会社 | シロドシン含有粒子の製造方法及びシロドシン含有口腔内崩壊錠の製造方法 |
| JP6303037B2 (ja) * | 2017-02-14 | 2018-03-28 | 杏林製薬株式会社 | イミダフェナシン含有口腔内速崩錠 |
-
2018
- 2018-10-29 JP JP2018203314A patent/JP7316777B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Murphy | Anticoagulant rodenticides | |
| JOP20210292A1 (ar) | مشتقات حمض إيتاكونيك واستخداماتها في علاج مرض التهابي أو مرض مصاحب لاستجابة مناعية غير مرغوب فيها | |
| EP4269601A3 (en) | Modified t cells and methods of making and using the same | |
| JP2016506747A5 (OSRAM) | ||
| WO2016149484A3 (en) | Compositions and methods for specific reactivation of hiv latent reservoir | |
| WO2018237037A3 (en) | HEAVY CHAIN ANTIBODY ONLY ANTI-BCMA | |
| JP2016512248A5 (OSRAM) | ||
| JP2015078230A5 (OSRAM) | ||
| CN104812762A8 (en) | Substituted annulated pyrimidines and triazines, and use thereof | |
| HK1247829A1 (zh) | 用於治疗HCV的β-D-2'-脱氧-2'Α-氟-2'-β-C-取代-2-改性N6-取代的嘌呤核苷酸 | |
| JP2019011379A5 (OSRAM) | ||
| JP2017155057A5 (OSRAM) | ||
| JP2017019841A5 (OSRAM) | ||
| JP2016513680A5 (OSRAM) | ||
| JP2018199643A5 (OSRAM) | ||
| JP2018123146A5 (OSRAM) | ||
| JP2014533256A5 (OSRAM) | ||
| JP2016175884A5 (OSRAM) | ||
| JP2017008001A5 (OSRAM) | ||
| PT4081502T (pt) | Co-cristal de cetoprofeno e a sua preparação, composições farmacêuticas compreendendo o mesmo e suas utilizações | |
| JP2019518052A5 (OSRAM) | ||
| JP2019077664A5 (OSRAM) | ||
| EP3099294A4 (en) | Pharmaceutical composition including 5-{4-(aminosulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2h)-furanone and capsule formulation including the pharmaceutical composition | |
| JP2017014151A5 (OSRAM) | ||
| JP2014240383A5 (OSRAM) |